The global medicinal mushroom market consists of various edible and medicinal mushrooms that exhibit several health benefits. Mushrooms such as shiitake, reishi, chaga, lion's mane, and cordyceps are considered medicinal due to their immune-boosting, anti-inflammatory, and antioxidant properties. They are rich in polysaccharides, vitamins, minerals, and amino acids. Medicinal mushrooms are used to treat cancer, heart disease, diabetes, obesity, Alzheimer's, fatigue, and other chronic conditions. The dried or powdered forms of these mushrooms are used in supplements, extracts, tinctures, and teas. They are also used ingredients in food & beverages as well as in personal care applications due to their anti-aging benefits. The growing awareness regarding various health benefits of mushrooms is driving increasing consumer demand.
The Global Medicinal Mushroom Market Demand is estimated to be valued at US$ 34.22 BN in 2024 and is expected to exhibit a CAGR of 8.2% over the forecast period 2024 to 2031.
Key Takeaways
Key players operating in the global medicinal mushroom market are Host Defense Mushrooms, Sun Potion, Four Sigmatic, Om Mushrooms, Real Mushrooms, MycoMedicinals, North American Medicinal Mushrooms (NAMM), Golden Eagle Herbs, Rainforest Herbs, FreshCap Mushrooms, Oriveda, Dr. Stamets' PerfectSpore, Fungi Perfecti, Redd Remedies, Vital Plankton, and Aloha Medicinals. These players are engaged in extensive research & development to expand their product portfolios and launching new medicinal mushroom varieties to cater to rising consumer demand.
The growing awareness about health benefits along with rising disposable income levels is driving increasing demand for medicinal mushrooms globally. Mushrooms are considered a highly nutritious superfood and their consumption is surging significantly among health-conscious consumers.
Major players are focusing on global expansion strategies to tap opportunities in emerging markets. The increasing popularity of medicinal mushrooms in Asia Pacific and Latin America is encouraging companies to enhance their footprint in these regions through strategic partnerships and collaborations. International markets offer massive growth potential as the Western world also embraces Eastern medicinal practices.
Market Drivers
The increasing prevalence of chronic lifestyle diseases and growing preference for natural remedies without side effects are major drivers propelling the global medicinal mushroom market. According to WHO, chronic diseases account for over 60% of global deaths annually. The anti-inflammatory and disease preventing qualities of medicinal mushrooms are prompting more patients and healthcare providers to include them in treatment regimens. Additionally, the boosting effect of mushrooms on immunity has become especially important amid the COVID-19 pandemic, further accentuating market growth.
Geopolitical Impact on Global Medicinal Mushroom Market Growth
The current geopolitical tensions and conflicts between major trading partners are negatively impacting the global medicinal mushroom market. Restrictions on trade and supply chain disruptions caused by sanctions and policy changes are hindering the easy availability of raw materials for several players in this industry. The Ukraine conflict has further complicated matters by disrupting exports from the region which is a major cultivator and producer of medicinal mushrooms like chaga, turkey tails, reishi etc. Rising geopolitical uncertainties and the threat of sanctions on key trading economies like China are raising input and operational costs. This is affecting the profit margins of companies. To deal with this volatile external environment, industry players will need to diversify their sourcing networks, develop alternative supplier routes, and localize production wherever possible to insulate themselves from reliance on high-risk regions. Strategic partnerships and contract growing agreements with cultivators in multiple geographies can help make supply chains more resilient.
Geographical Regions with Highest Market Value for Global Medicinal Mushroom Market
North America currently accounts for the largest share of the global medicinal mushroom market in terms of value, estimated at around 35% of the total industry revenues. This is mainly due to rising consumer awareness about the medicinal benefits of mushrooms and their usage in alternative medicine practices which are very popular in the region. The U.S. makes up the bulk of demand supported by the presence of a large health-conscious consumer base and growth of natural health products industry. Europe is the second major regional market dominated by countries like Germany, France, U.K. which have traditionally used medicinal mushrooms in their culinary practices as well as medicine systems. The Asia Pacific region is concentrated around China, Japan, South Korea which are key cultivators, producers and consumers due to the deep historical roots of medical mushroom usage in these countries.
Fastest Growing Regional Market for the Global Medicinal Mushroom Industry
The Asia Pacific region excluding Japan (APEJ) market for medicinal mushrooms is expected to be the fastest growing globally through the forecast period driven by population expansion, rising disposable incomes, and growing health awareness in developing countries like India and Indonesia. The easy availability of suitable climatic conditions and cultivation expertise makes this a strategic growth market. Industry players are keenly focusing on partnerships and investments to expand their presence, production and retail networks in the high potential APEJ region where demand for traditional medicines using mushrooms is experiencing a major revival. The comparatively lower sourcing and manufacturing costs also favor industry profitability in these countries.
Get more insights on this topic: Medicinal Mushroom Market